PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS
Provided is a pyrazolo[1,5-a]pyrimidine compound represented by the general formula [I]:wherein each symbol is as defined in the description, or a salt thereof, having PAR2 inhibitory activity, and a pharmaceutical composition comprising the same.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TAKAHASHI, Akira WATANABE, Kenji YUKI, Yohei OKADA, Minoru SAITO, Akihiro YAMAGUCHI, Atsushi UEMATSU, Yukitaka HANARI, Taiki YAMAUCHI, Takahito NAKAMURA, Yuichi MATSUDA, Satoshi MENJO, Yasuhiro |
| description | Provided is a pyrazolo[1,5-a]pyrimidine compound represented by the general formula [I]:wherein each symbol is as defined in the description, or a salt thereof, having PAR2 inhibitory activity, and a pharmaceutical composition comprising the same. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024376109A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024376109A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024376109A13</originalsourceid><addsrcrecordid>eNrjZPAIiAxyjPL38Y821DHVdYwFcj19PV08_VwVnP19A_xD_VwU3PyDFEI8XBVCglwdQ3xd_UIU_N0UXFyDfB19FFw8g_2DgOxgHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSHxpsZGBkYmxuZmhg6WhoTJwqAOTjLhM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS</title><source>esp@cenet</source><creator>TAKAHASHI, Akira ; WATANABE, Kenji ; YUKI, Yohei ; OKADA, Minoru ; SAITO, Akihiro ; YAMAGUCHI, Atsushi ; UEMATSU, Yukitaka ; HANARI, Taiki ; YAMAUCHI, Takahito ; NAKAMURA, Yuichi ; MATSUDA, Satoshi ; MENJO, Yasuhiro</creator><creatorcontrib>TAKAHASHI, Akira ; WATANABE, Kenji ; YUKI, Yohei ; OKADA, Minoru ; SAITO, Akihiro ; YAMAGUCHI, Atsushi ; UEMATSU, Yukitaka ; HANARI, Taiki ; YAMAUCHI, Takahito ; NAKAMURA, Yuichi ; MATSUDA, Satoshi ; MENJO, Yasuhiro</creatorcontrib><description>Provided is a pyrazolo[1,5-a]pyrimidine compound represented by the general formula [I]:wherein each symbol is as defined in the description, or a salt thereof, having PAR2 inhibitory activity, and a pharmaceutical composition comprising the same.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241114&DB=EPODOC&CC=US&NR=2024376109A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241114&DB=EPODOC&CC=US&NR=2024376109A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAKAHASHI, Akira</creatorcontrib><creatorcontrib>WATANABE, Kenji</creatorcontrib><creatorcontrib>YUKI, Yohei</creatorcontrib><creatorcontrib>OKADA, Minoru</creatorcontrib><creatorcontrib>SAITO, Akihiro</creatorcontrib><creatorcontrib>YAMAGUCHI, Atsushi</creatorcontrib><creatorcontrib>UEMATSU, Yukitaka</creatorcontrib><creatorcontrib>HANARI, Taiki</creatorcontrib><creatorcontrib>YAMAUCHI, Takahito</creatorcontrib><creatorcontrib>NAKAMURA, Yuichi</creatorcontrib><creatorcontrib>MATSUDA, Satoshi</creatorcontrib><creatorcontrib>MENJO, Yasuhiro</creatorcontrib><title>PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS</title><description>Provided is a pyrazolo[1,5-a]pyrimidine compound represented by the general formula [I]:wherein each symbol is as defined in the description, or a salt thereof, having PAR2 inhibitory activity, and a pharmaceutical composition comprising the same.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAIiAxyjPL38Y821DHVdYwFcj19PV08_VwVnP19A_xD_VwU3PyDFEI8XBVCglwdQ3xd_UIU_N0UXFyDfB19FFw8g_2DgOxgHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSHxpsZGBkYmxuZmhg6WhoTJwqAOTjLhM</recordid><startdate>20241114</startdate><enddate>20241114</enddate><creator>TAKAHASHI, Akira</creator><creator>WATANABE, Kenji</creator><creator>YUKI, Yohei</creator><creator>OKADA, Minoru</creator><creator>SAITO, Akihiro</creator><creator>YAMAGUCHI, Atsushi</creator><creator>UEMATSU, Yukitaka</creator><creator>HANARI, Taiki</creator><creator>YAMAUCHI, Takahito</creator><creator>NAKAMURA, Yuichi</creator><creator>MATSUDA, Satoshi</creator><creator>MENJO, Yasuhiro</creator><scope>EVB</scope></search><sort><creationdate>20241114</creationdate><title>PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS</title><author>TAKAHASHI, Akira ; WATANABE, Kenji ; YUKI, Yohei ; OKADA, Minoru ; SAITO, Akihiro ; YAMAGUCHI, Atsushi ; UEMATSU, Yukitaka ; HANARI, Taiki ; YAMAUCHI, Takahito ; NAKAMURA, Yuichi ; MATSUDA, Satoshi ; MENJO, Yasuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024376109A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TAKAHASHI, Akira</creatorcontrib><creatorcontrib>WATANABE, Kenji</creatorcontrib><creatorcontrib>YUKI, Yohei</creatorcontrib><creatorcontrib>OKADA, Minoru</creatorcontrib><creatorcontrib>SAITO, Akihiro</creatorcontrib><creatorcontrib>YAMAGUCHI, Atsushi</creatorcontrib><creatorcontrib>UEMATSU, Yukitaka</creatorcontrib><creatorcontrib>HANARI, Taiki</creatorcontrib><creatorcontrib>YAMAUCHI, Takahito</creatorcontrib><creatorcontrib>NAKAMURA, Yuichi</creatorcontrib><creatorcontrib>MATSUDA, Satoshi</creatorcontrib><creatorcontrib>MENJO, Yasuhiro</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAKAHASHI, Akira</au><au>WATANABE, Kenji</au><au>YUKI, Yohei</au><au>OKADA, Minoru</au><au>SAITO, Akihiro</au><au>YAMAGUCHI, Atsushi</au><au>UEMATSU, Yukitaka</au><au>HANARI, Taiki</au><au>YAMAUCHI, Takahito</au><au>NAKAMURA, Yuichi</au><au>MATSUDA, Satoshi</au><au>MENJO, Yasuhiro</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS</title><date>2024-11-14</date><risdate>2024</risdate><abstract>Provided is a pyrazolo[1,5-a]pyrimidine compound represented by the general formula [I]:wherein each symbol is as defined in the description, or a salt thereof, having PAR2 inhibitory activity, and a pharmaceutical composition comprising the same.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2024376109A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T12%3A07%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAKAHASHI,%20Akira&rft.date=2024-11-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024376109A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |